Carotid Artery Disease Clinical Trial
Official title:
ARMOUR: Proximal Protection With The Mo.Ma Device During Carotid Stenting
The objective of the ARMOUR study is to evaluate the safety and effectiveness of the Mo.Ma proximal flow blockage cerebral protection device for patients at high surgical risk for carotid endarterectomy who undergo carotid artery stenting
Test Device:
Mo.Ma™ Proximal Flow Blockage Cerebral Protection Device. Single size catheter device with a
9 French introducer sheath compatible shaft (outer diameter) and a 6 French compatible
working channel (inner diameter), integrating two compliant balloons intended to achieve
endovascular clamping of external carotid arteries (ECA) 3-6 mm in diameter and common
carotid arteries (CCA) 5-13 mm in diameter.
Primary Objective:
Evaluate the safety and effectiveness of the Mo.Ma device for cerebral protection in the
treatment of internal carotid artery (ICA) stenoses, which may or may not involve the
bifurcation of the CCA, in subjects considered to be at high surgical risk for complications
during carotid endarterectomy (CEA).
Primary Endpoint:
Major adverse cardiac and cerebrovascular events (MACCE) within 30 days of implantation.
MACCE are defined as: any myocardial infarction (MI), stroke, or death through day 30
post-procedure.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02124928 -
Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
|
N/A | |
| Active, not recruiting |
NCT01597453 -
NOR-SYS: The Norwegian Stroke in the Young Study
|
N/A | |
| Completed |
NCT00231231 -
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)
|
Phase 3 | |
| Completed |
NCT00597974 -
Neurological Outcome With Carotid Artery Stenting
|
N/A | |
| Completed |
NCT00587717 -
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue
|
N/A | |
| Completed |
NCT02536378 -
POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE
|
||
| Completed |
NCT02126982 -
Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence
|
||
| Active, not recruiting |
NCT01445613 -
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
|
N/A | |
| Terminated |
NCT01414387 -
Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting
|
N/A | |
| Completed |
NCT00406055 -
CHOICE: Carotid Stenting For High Surgical-Risk Patients
|
Phase 4 | |
| Completed |
NCT00403078 -
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
|
||
| Terminated |
NCT01968226 -
TRACER RGD-K5 Carotid Plaque Imaging Study
|
Phase 2 | |
| Completed |
NCT01685567 -
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
|
Phase 3 | |
| Completed |
NCT00402740 -
Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)
|
N/A | |
| Completed |
NCT00287508 -
Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)
|
Phase 4 | |
| Completed |
NCT00178672 -
A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease
|
Phase 4 | |
| Recruiting |
NCT02850588 -
SVS VQI TransCarotid Revascularization Surveillance Project
|
||
| Completed |
NCT02759653 -
Norwegian Carotid Plaque Study
|
||
| Withdrawn |
NCT01042912 -
Frequency Analysis of Carotid Artery Disease
|
N/A | |
| Completed |
NCT00530504 -
Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study
|
N/A |